Skin that feels dry or lacks bounce
Patients turn the dose selector until the desired dose (0.25 mg, 0.5 mg, 1 mg, or 2 mg) aligns with the dose pointer in the window
GLP-1 receptor agonists (GLP-1s) are a class of medications originally developed to treat type 2 diabetes, but theyve also emerged as a transformative option for managing obesity and metabolic syndrome
People with a prior kidney stone history or chronic kidney disease face higher risk
It is also useful in improving cardiovascular functioning, and conditions like diabetes, high blood pressure, arthritis, and high cholesterol
These inconsistencies highlight the importance of a substrate-centered metabolic perspective